Judith G. Pool, Edwabd J. Hershgold, Albert R. Pappenhagen: High-potency Antihæmophilic Factor Concentrate prepared from Cryoglobulin Precipitate. In: Nature. Band203, Nr.4942, Juli 1964, ISSN0028-0836, S.312–312, doi:10.1038/203312a0 (nature.com [abgerufen am 20. Mai 2019]).
B. Nascimento, L. T. Goodnough, J. H. Levy: Cryoprecipitate therapy. In: British Journal of Anaesthesia. Band113, Nr.6, Dezember 2014, S.922–934, doi:10.1093/bja/aeu158 (elsevier.com [abgerufen am 20. Mai 2019]).
Judith Graham Pool, Angela E. Shannon: Production of High-Potency Concentrates of Antihemophilic Globulin in a Closed-Bag System: Assay in Vitro and in Vivo. In: New England Journal of Medicine. Band273, Nr.27, 30. Dezember 1965, ISSN0028-4793, S.1443–1447, doi:10.1056/NEJM196512302732701 (nejm.org [abgerufen am 20. Mai 2019]).
J. Mahlangu, J. Oldenburg, I. Paz‑Priel, C. Negrier, M. Niggli, M. E. Mancuso, C. Schmitt, V. Jiménez‑Yuste, C. Kempton, C. Dhalluin, M. U. Callaghan, W. Bujan, M. Shima, J. I. Adamkewicz, E. Asikanius, G. G. Levy, R. Kruse‑Jarres: Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors. In: The New England Journal of Medicine. Band379, Nr.9, 2018, S.811–822, doi:10.1056/NEJMoa1803550.
M. Callaghan, C. Negrier, I. Paz-Priel u. a.: Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1-4 studies. In: Blood. Band137, Nr.16, 2021, S.2231–2242, doi:10.1182/blood.2020009217.
Lindsey A. George u. a.: Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant. In: New England Journal of Medicine. Nr.377, 2017, S.2215–2227, doi:10.1056/NEJMoa1708538.
K. John Pasi u. a.: Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A. In: New England Journal of Medicine. Nr.382, 2020, S.29–40, doi:10.1056/NEJMoa1908490.
elsevier.com
linkinghub.elsevier.com
B. Nascimento, L. T. Goodnough, J. H. Levy: Cryoprecipitate therapy. In: British Journal of Anaesthesia. Band113, Nr.6, Dezember 2014, S.922–934, doi:10.1093/bja/aeu158 (elsevier.com [abgerufen am 20. Mai 2019]).
Judith G. Pool, Edwabd J. Hershgold, Albert R. Pappenhagen: High-potency Antihæmophilic Factor Concentrate prepared from Cryoglobulin Precipitate. In: Nature. Band203, Nr.4942, Juli 1964, ISSN0028-0836, S.312–312, doi:10.1038/203312a0 (nature.com [abgerufen am 20. Mai 2019]).
nejm.org
Judith Graham Pool, Angela E. Shannon: Production of High-Potency Concentrates of Antihemophilic Globulin in a Closed-Bag System: Assay in Vitro and in Vivo. In: New England Journal of Medicine. Band273, Nr.27, 30. Dezember 1965, ISSN0028-4793, S.1443–1447, doi:10.1056/NEJM196512302732701 (nejm.org [abgerufen am 20. Mai 2019]).
Judith G. Pool, Edwabd J. Hershgold, Albert R. Pappenhagen: High-potency Antihæmophilic Factor Concentrate prepared from Cryoglobulin Precipitate. In: Nature. Band203, Nr.4942, Juli 1964, ISSN0028-0836, S.312–312, doi:10.1038/203312a0 (nature.com [abgerufen am 20. Mai 2019]).
Judith Graham Pool, Angela E. Shannon: Production of High-Potency Concentrates of Antihemophilic Globulin in a Closed-Bag System: Assay in Vitro and in Vivo. In: New England Journal of Medicine. Band273, Nr.27, 30. Dezember 1965, ISSN0028-4793, S.1443–1447, doi:10.1056/NEJM196512302732701 (nejm.org [abgerufen am 20. Mai 2019]).